Spravato® (Esketamine) Treatment Coverage
Spravato® is FDA-approved for treatment-resistant depression. Many insurance plans cover Spravato® when medical criteria are met. Our team will work with your insurance company to obtain prior authorization and ensure all requirements are met before starting treatment.
TMS Therapy Coverage
Transcranial Magnetic Stimulation (TMS) is often covered by insurance for depression and certain other conditions when criteria are met. We assist with the pre-authorization process to help you begin treatment as soon as possible.
iChange One-Day Accelerated TMS
Our most time-efficient intensive TMS option.
The iChange One-Day Accelerated TMS program delivers a complete series of closely spaced intermittent theta-burst stimulation treatments during a single treatment day.
Treatment Day
20 iTBS treatment sessions
Approximately 3 minutes of stimulation per session, with scheduled recovery intervals between treatments.
Plan for approximately 10 hours at the center.
Your Program Includes
- Physician psychiatric evaluation
- TMS candidacy assessment
- Motor-threshold determination
- Treatment localization and mapping
- 20 iTBS sessions
- Continuous clinical supervision throughout the treatment day
- Vital-sign monitoring as clinically appropriate
- Standardized depression assessments
- Post-treatment outcome monitoring
- Follow-up assessment
Neuroplasticity Enhancement
For appropriate patients, the physician may consider pharmacologic strategies intended to support neuroplasticity during accelerated TMS.
These medications are prescribed only after individualized medical evaluation and when clinically appropriate.
One-Day Program: $6,000
One-day accelerated TMS is an intensive treatment approach using an FDA-cleared TMS device in a treatment schedule that differs from standard FDA-cleared TMS courses. Certain aspects of the protocol, including accelerated scheduling and pharmacologic augmentation when used, may be off-label or investigational. Treatment is offered only after physician evaluation and determination of medical appropriateness. Individual outcomes vary.
